跳到正文

OrbiMed Capital GP VII LLC 内部人交易:近期 SEC Form 4 交易

过去 18 个月,OrbiMed Capital GP VII LLC(CIK 1760648)在 6 家公司共报告 33 笔 SEC Form 4 内部人交易(最近一笔 2026-09-30)。

日期公司身份类型股数市值
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入10.7M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入2.0M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入769,601$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入564,187$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入300,249$5.1M
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入7.1M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入1.3M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入513,067$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入256,448$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入61,516$1.0M
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入588,235$10.0M
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入1.1M$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入2.0M$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入1.7M$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入333,333$5.0M
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入758,279$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入1.0M$15.0M
2026-06-24Enliven Therapeutics, Inc. (ELVN)10% 以上股东卖出24,846$1.1M
2026-06-24Enliven Therapeutics, Inc. (ELVN)10% 以上股东卖出1,477$66,465
2026-06-24Enliven Therapeutics, Inc. (ELVN)10% 以上股东卖出787,024$35.7M
2026-06-24Enliven Therapeutics, Inc. (ELVN)10% 以上股东卖出46,776$2.1M
2026-06-17Enliven Therapeutics, Inc. (ELVN)10% 以上股东卖出9,086$409,052
2026-06-17Enliven Therapeutics, Inc. (ELVN)10% 以上股东卖出272,322$12.3M
2026-06-01Q32 Bio Inc. (QTTB)董事买入1.2M$10.0M
2026-06-01Q32 Bio Inc. (QTTB)董事买入625,000$5.0M

来源:SEC Form 4 申报文件 · 截至 2026-09-30